Emad Abdelnaby
Senior Vice President, Head of Commercial Legend Biotech
Emad Abdelnaby is Senior Vice President and Head of Commercial at Legend Biotech, where he leads commercial strategy for advanced cell therapy programs including Carvykti. He is a dynamic, global, commercial leader of healthcare businesses with experience leading US and internationally based teams and driving growth across complex healthcare organizations. His work includes managing sizable P&Ls, leading extensive cross-functional teams, and synthesizing data into the development of clear business objectives and strategies.
Seminars
Wednesday 16th September 2026
Industry Leader’s Fireside Chat: Evaluating the CAR & TCR Therapeutic & Commercial Landscape to Propel Advanced Cell Therapy Innovation, Expand Treatment Options & Ensure Positive Commercial Outcomes
8:20 am
- Highlighting evolving modality innovations and industry shifts to demonstrate how rapid scientific and technological progress is enhancing treatment accessibility and reshaping the cell therapy landscape
- Aligning clinical development, scalability and patient access strategies to accelerate commercialization pathways across advanced cell therapy modalities
- Discussing post-approval reimbursement policies and strategies to ensure long-term commercial success
- Predicting cell therapy evolution through 2026 and beyond to provide strategic and commercial foresight
